Gossamer Bio (GOSS) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 2.02 | 1.59 | 0.65 | 0.14 | 0.49 | 2.49 | |||
Changes by years, y/y, % | -14% | -22% | -59% | -79% | +251% | -27.0% |
Gossamer Bio. Debt/EBITDA
Gossamer Bio. Debt/EBITDA, changes, %
Gossamer Bio (GOSS) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | -0.30 | 0.66 | 0.53 | 0.23 | 2.49 | 2.49 | ||
Changes by years, y/y, % | +1 109% | +261% | +279% | -329% | -932% | |||
Changes by quarters, q/q, % | +197% | -320% | -19% | -57% | +981% |